GLSI logo

GLSIGreenwich LifeSciences Inc

$22.11
$0.12
(0.54%)
Today
Closed $22.11
$0.03
(0.14%)
After Hours
Updated: 06:46 PM EDT
EarningsAug 13
Mkt Cap$326.3M
Vol64,576.00
News
all
press releases
GLSI Stock Climbs After Removing A Key Overhang – Retail Turns Focus To High-Stakes Breast Cancer Trial
Greenwich LifeSciences said the delay in filing Form 10-K was due to accounting adjustments tied to stronger-than-expected patient enrollment in its Phase III trial to treat breast cancer.
Stocktwits
News Placeholder
More News
News Placeholder
Greenwich LifeSciences (NASDAQ:GLSI) Cut to "Sell" at Wall Street Zen
Wall Street Zen lowered shares of Greenwich LifeSciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat
News Placeholder
HC Wainwright Has Bearish Estimate for GLSI FY2026 Earnings
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Greenwich LifeSciences in a research report issued on...
MarketBeat
News Placeholder
Why Did GLSI Stock Rise Pre-Market Today?
The company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted
Stocktwits
News Placeholder
Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Tuesday
Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, April 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-21-greenwich-lifesciences-inc-stock...
MarketBeat
News Placeholder
Greenwich LifeSciences (GLSI) Expected to Announce Quarterly Earnings on Tuesday
Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, March 31. (View Earnings Report at...
MarketBeat
News Placeholder
Why Is GLSI Stock Rising Today?
Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year.
Stocktwits
News Placeholder
Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Should You Buy?
Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Time to Buy...
MarketBeat
News Placeholder
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 14.7% in January
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) was the target of a significant drop in short interest in January. As of January 30th, there was short interest totaling 1,318,481 shares...
MarketBeat
News Placeholder
HC Wainwright Issues Positive Forecast for GLSI Earnings
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Stock analysts at HC Wainwright upped their Q3 2026 earnings per share estimates for Greenwich LifeSciences in a report released on...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.